ASX - By Stock
|
NEU |
Re:
NEU is materially undervalued
|
|
DKEL
|
64 |
35K |
10 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
64
|
35K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 added to WHO List of Antibacterial Products
|
|
DKEL
|
25 |
8.5K |
4 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
25
|
8.5K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Murdoch Children's R327 Efficacy N.gonorrhoeae in-vivo
|
|
DKEL
|
13 |
3.9K |
1 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
13
|
3.9K
|
1
|
|
ASX - By Stock
|
CGC |
Re:
Ann: Revised offer from Paine Schwartz Partners
|
|
DKEL
|
13 |
5.0K |
6 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
13
|
5.0K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
DKEL
|
124 |
42K |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
124
|
42K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update
|
|
DKEL
|
165 |
36K |
5 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
165
|
36K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAA SHARE HOLDERS AS AT 30TH MARCH 2023
|
|
DKEL
|
7 |
3.1K |
7 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
7
|
3.1K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Completes Enrolment of First Patient Cohort
|
|
DKEL
|
98 |
22K |
9 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
98
|
22K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Completes Enrolment of First Patient Cohort
|
|
DKEL
|
98 |
22K |
7 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
98
|
22K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DKEL
|
3 |
2.3K |
6 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
3
|
2.3K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA appoints trial manager & receives $200k from FightMND
|
|
DKEL
|
21 |
5.4K |
12 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
21
|
5.4K
|
12
|
|
ASX - By Stock
|
COE |
Re:
AEMO reading
|
|
DKEL
|
863 |
346K |
7 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
863
|
346K
|
7
|
|
ASX - By Stock
|
COE |
Re:
Ann: Orbost Gas Processing Plant - Phase 2B works presentation
|
|
DKEL
|
27 |
6.5K |
0 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
27
|
6.5K
|
0
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Update on Administration
|
|
DKEL
|
16 |
14K |
5 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
16
|
14K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden University Medical Centre Monepantel COVID-19 Testing
|
|
DKEL
|
105 |
22K |
5 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
105
|
22K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
HC PAA SH Volume
|
|
DKEL
|
180 |
41K |
3 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
180
|
41K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
DKEL
|
194 |
51K |
2 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
194
|
51K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
DKEL
|
194 |
51K |
5 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
194
|
51K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Elanco Option Update
|
|
DKEL
|
194 |
51K |
6 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
194
|
51K
|
6
|
|
ASX - By Stock
|
COE |
Re:
Ann: Sole Orbost Update 19 June 2020
|
|
DKEL
|
151 |
55K |
5 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
151
|
55K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Oral Data on New RECCE 435 Against H. pylori
|
|
DKEL
|
25 |
8.9K |
1 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
25
|
8.9K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Oral Data on New RECCE 435 Against H. pylori
|
|
DKEL
|
25 |
8.9K |
1 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
25
|
8.9K
|
1
|
|
ASX - By Stock
|
CGC |
Re:
Share price today?
|
|
DKEL
|
19 |
10K |
3 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
19
|
10K
|
3
|
|
ASX - By Stock
|
NZS |
Re:
4c fair value ($30M), 8c short term target ($60M)
|
|
DKEL
|
2.0K |
521K |
9 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
2.0K
|
521K
|
9
|
|
ASX - By Stock
|
COE |
Re:
Ann: Sole Gas Project update
|
|
DKEL
|
18 |
9.6K |
0 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
18
|
9.6K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Virtual Investor Briefing Presentation
|
|
DKEL
|
148 |
32K |
5 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
148
|
32K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Suspension from Official Quotation
|
|
DKEL
|
59 |
16K |
12 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
59
|
16K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
What time will the Trading halt lift?
|
|
DKEL
|
67 |
17K |
14 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
67
|
17K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4D & Financial Report
|
|
DKEL
|
20 |
8.6K |
5 |
05/03/19 |
05/03/19 |
ASX - By Stock
|
20
|
8.6K
|
5
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Trading Halt
|
|
DKEL
|
154 |
74K |
7 |
31/12/18 |
31/12/18 |
ASX - By Stock
|
154
|
74K
|
7
|
|
ASX - By Stock
|
NEU |
Dementia
|
|
DKEL
|
4 |
2.7K |
10 |
26/04/16 |
26/04/16 |
ASX - By Stock
|
4
|
2.7K
|
10
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Letter to Shareholders
|
|
DKEL
|
8 |
5.0K |
5 |
17/12/15 |
17/12/15 |
ASX - By Stock
|
8
|
5.0K
|
5
|
|
ASX - By Stock
|
PEN |
Re:
Ann: Peninsula Advances Planned USA Listing
|
|
DKEL
|
9 |
4.5K |
3 |
16/11/15 |
16/11/15 |
ASX - By Stock
|
9
|
4.5K
|
3
|
|
ASX - By Stock
|
BNO |
Re:
Ann: BNC101 FDA SUBMISSION SUCCESSFUL
|
|
DKEL
|
11 |
4.8K |
0 |
08/09/15 |
08/09/15 |
ASX - By Stock
|
11
|
4.8K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Ann: BNC101 FDA SUBMISSION SUCCESSFUL
|
|
DKEL
|
11 |
4.8K |
1 |
05/09/15 |
05/09/15 |
ASX - By Stock
|
11
|
4.8K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C - Quarterly Report & Company Update
|
|
DKEL
|
72 |
21K |
1 |
04/08/15 |
04/08/15 |
ASX - By Stock
|
72
|
21K
|
1
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 27 July
|
|
DKEL
|
175 |
42K |
1 |
28/07/15 |
28/07/15 |
ASX - Short Term Trading
|
175
|
42K
|
1
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 20 July
|
|
DKEL
|
267 |
53K |
0 |
23/07/15 |
23/07/15 |
ASX - Short Term Trading
|
267
|
53K
|
0
|
|
ASX - By Stock
|
PEN |
Re:
Don't ruin a "perfect week"
|
|
DKEL
|
8 |
5.7K |
0 |
18/07/15 |
18/07/15 |
ASX - By Stock
|
8
|
5.7K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Two Canines Complete Combination Therapy With PPL-1
|
|
DKEL
|
92 |
25K |
4 |
16/07/15 |
16/07/15 |
ASX - By Stock
|
92
|
25K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann out First Dog Shows Suppression of Cancer Marker
|
|
DKEL
|
86 |
23K |
2 |
06/05/15 |
06/05/15 |
ASX - By Stock
|
86
|
23K
|
2
|
|
ASX - By Stock
|
PBP |
Re:
Ann: Update on ADP protein Plant
|
|
DKEL
|
17 |
8.2K |
0 |
23/04/15 |
23/04/15 |
ASX - By Stock
|
17
|
8.2K
|
0
|
|
ASX - By Stock
|
PEN |
Re:
20,000,000 buyer
|
|
DKEL
|
23 |
9.7K |
3 |
23/04/15 |
23/04/15 |
ASX - By Stock
|
23
|
9.7K
|
3
|
|
ASX - By Stock
|
VMT |
Re:
Shandong EV Expo in China
|
|
DKEL
|
14 |
8.1K |
0 |
28/03/15 |
28/03/15 |
ASX - By Stock
|
14
|
8.1K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Bounce time imminent!
|
|
DKEL
|
212 |
80K |
1 |
24/03/15 |
24/03/15 |
ASX - By Stock
|
212
|
80K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Bounce time imminent!
|
|
DKEL
|
212 |
80K |
1 |
24/03/15 |
24/03/15 |
ASX - By Stock
|
212
|
80K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Change in substantial holding
|
|
DKEL
|
4 |
2.2K |
0 |
10/03/15 |
10/03/15 |
ASX - By Stock
|
4
|
2.2K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives response to request for Breakthrough Therapy
|
|
DKEL
|
57 |
31K |
12 |
02/03/15 |
02/03/15 |
ASX - By Stock
|
57
|
31K
|
12
|
|
ASX - By Stock
|
VMT |
Re:
agm summary
|
|
DKEL
|
37 |
2.1K |
2 |
17/05/13 |
17/05/13 |
ASX - By Stock
|
37
|
2.1K
|
2
|
|
ASX - By Stock
|
VMT |
Re:
news
|
|
DKEL
|
44 |
2.8K |
3 |
05/02/13 |
05/02/13 |
ASX - By Stock
|
44
|
2.8K
|
3
|
|